[Featured Stock] Korea Biogen Strengthens SoBuJang Competitiveness Season 2... Reevaluation of the Only Domestic Silicon Material Company

[Asia Economy Reporter Park Hyungsoo] The stock price of Hanguk Biogen is on the rise. Expectations that the government will strengthen support for materials, parts, and equipment companies appear to have influenced the stock price.

As of 10:15 AM on the 24th, Hanguk Biogen is trading at 7,280 KRW, up 14.47% from the previous day.

The ruling party and government have decided to supplement and review the localization measures for materials, parts, and equipment (SoBuJang) in response to the expected additional trade retaliation measures from the Japanese government following the court's commencement of domestic asset sales of Japanese forced labor companies.

Kim Tae-nyeon, floor leader of the Democratic Party of Korea, stated at the SoBuJang party-government review meeting held at the National Assembly on the morning of the 24th, "We must review and supplement the current issues of SoBuJang measures to ensure swift action in case of additional Japanese retaliation," adding, "The Democratic Party will start Season 2 of the SoBuJang industry strategy."

Established in March 2001, Hanguk Biogen is a precision chemical company specializing in the development, application, and production of multipurpose silicon-related materials. It produces functional silicon materials, which were previously 100% imported, using its own technology, thereby substituting imports and exporting. Hanguk Biogen is the only company in Korea that independently synthesizes functional silicon materials. It is expected that the materials supplied by Hanguk Biogen will make significant contributions to related industries in the future.

Release films require the use of relatively expensive fluorine-based films, and the market is monopolized by a limited number of advanced suppliers, including Japan's Shin-Etsu, for fluorine release coating agents. The fluorine-based release coating agent developed by Hanguk Biogen is a curing system based on hydrosilylation under a platinum catalyst. The company independently developed MQ resin, a special type of silicone, and is the only domestic supplier exporting it overseas.

Hanguk Biogen was also included among the 100 domestic small and strong companies selected by the government at the end of last year to respond to Japan's export restrictions on core materials. Since the selection was made through strict evaluation of the necessity of localization of materials, parts, and equipment and the potential to contribute to future new industries, expectations for growth through government support are high.

Park Chansol, a researcher at SK Securities, predicted, "Since it has global price competitiveness for MQ resin raw materials, it will drive sales growth this year."

This content was produced with the assistance of AI translation services.